Industry News
Show
- Weight and Obesity
- The FDA Has Approved An Obesity Drug That Helped Some People Drop Weight By 15%
- In company-funded studies, participants taking Wegovy had an average weight loss of 15%, about 34 pounds (15.3 kilograms).
- 533 0
- Alzheimer's Disease
- FDA Grants Accelerated Approval for Alzheimer’s Drug
- According to a press announcement, the FDA has approved Aduhelm (aducanumab) for the treatment of Alzheimer’s disease
- 516 0
- Weight and Obesity
- FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014
- This is the first approved drug for chronic weight management in adults with general obesity or overweight since 2014.
- 657 0
- Infectious Disease
- Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication
- SARS-CoV-2 antibody tests should not be used to evaluate a person’s level of immunity or protection from COVID-19 at any time, and especially after ...
- 1578 0
-
- Weight and Obesity
- The FDA Has Approved An Obesity Drug That Helped Some People Drop Weight By 15%
- In company-funded studies, participants taking Wegovy had an average weight loss of 15%, about 34 pounds (15.3 kilograms).
- 533 0
-
- Alzheimer's Disease
- FDA Grants Accelerated Approval for Alzheimer’s Drug
- According to a press announcement, the FDA has approved Aduhelm (aducanumab) for the treatment of Alzheimer’s disease
- 516 0
-
- Weight and Obesity
- FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014
- This is the first approved drug for chronic weight management in adults with general obesity or overweight since 2014.
- 657 0
-
- Infectious Disease
- Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication
- SARS-CoV-2 antibody tests should not be used to evaluate a person’s level of immunity or protection from COVID-19 at any time, and especially after ...
- 1578 0
Load More
